OliveSEcksteinMD
Pediatric Hematology & Oncology • Houston, TXCancer Genetics/Cancer Risk Assessment, Pediatric Hematologic Oncology
Assistant Professor
Dr. Eckstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6621 Fannin St
Cancer and Hematology Centers
Houston, TX 77030Phone+1 832-824-1000- Is this information wrong?
Summary
- Dr. Olive Eckstein is a pediatric hematologist/oncologist in Houston, TX and is affiliated with Texas Children's Hospital. She received her medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice for over 10 years. She specializes in histiocytic disorders (including HLH, LCH, Rosai-Dorfman disease, juvenile xanthogranuloma), lymphomas, lymphoproliferative disorders, cancer genetics, and pediatric hematologic oncology and is experienced in general pediatric hematology-oncology and pediatric hematopoietic stem cell transplantation.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2007 - 2010
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2007
Certifications & Licensure
TX State Medical License 2014 - 2025
OH State Medical License 2010 - 2013- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha
Clinical Trials
- Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH) Start of enrollment: 2016 Mar 07
- Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders Start of enrollment: 2021 Apr 19
- Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis Start of enrollment: 2021 Jul 13
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.Agrusa, J. E., Deevyashali Parekh, Howard Lin, Akanksha Batajoo, Erin Peckham-Gregory, Vivekanudeep Karri, Whitney Stanton, Brooks Scull, Ryan Fleishmann, Nader El-Mal...> ;British Journal of Haematology. 2024 Mar 19
- Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis.Agrusa, J. E., Vivekanudeep Karri, Howard Lin, Jessica Velazquez, Akanksha Batajoo, Deevyashali Parekh, Whitney Stanton, Harshal Abhyankar, Nader K El-Mallawany, Jenni...> ;British Journal of Haematology. 2024 Mar 19
- Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.Chandrakasan, S., Jordan, M., Baker, A., Behrens, E., Bhatla, D., Chien, M., Eckstein, O., Henry, M., Hermiston, M., Hinson, A., Leiding, J., Oladapo, A., Patel, S., P...> ;Blood Advances. 2024 Mar 1
- Join now to see all
Abstracts/Posters
- Comprehensive Cell Specific Transcriptome Profiling of a Pediatric Hodgkin Lymphoma CohortOlive S. Eckstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphoh...Olive S. Eckstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Hospital Affiliations
Texas Children's HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
